Tag: October 14, 2024 revenue disclosure
Unlocking Tevogen Bio’s $1B+ Revenue Potential: Pipeline Portfolio Revealed (Oct 14, 2024)
Tevogen Bio, a biotech company focused on developing T cell therapeutics for infectious diseases and cancers, recently shared its projected $1B+ revenue potential, highlighting...
BREAKING NEWS
Los Angeles Wildfires Death Toll Reaches 10, Officials Confirm
Los Angeles Wildfires Death Toll Reaches 10, Officials ConfirmA devastating tragedy struck the heart of Los Angeles as the death toll in the ongoing...